Metropolitan Life Insurance Company (MetLife)’s Zynex ZYXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,205
Closed -$14.9K 2166
2024
Q1
$14.9K Hold
1,205
﹤0.01% 1990
2023
Q4
$13.1K Hold
1,205
﹤0.01% 2084
2023
Q3
$9.64K Hold
1,205
﹤0.01% 2225
2023
Q2
$11.6K Hold
1,205
﹤0.01% 2227
2023
Q1
$14.5K Sell
1,205
-149
-11% -$1.95K ﹤0.01% 2026
2022
Q4
$18.8K Hold
1,354
﹤0.01% 2045
2022
Q3
$12.3K Buy
+1,354
New +$11.8K ﹤0.01% 2241
2021
Q4
Sell
-6,266
Closed -$64.9K 2834
2021
Q3
$64.9K Buy
+6,266
New +$80.5K ﹤0.01% 2723
2020
Q4
Sell
-6,415
Closed -$102K 2579
2020
Q3
$102K Hold
6,415
﹤0.01% 2212
2020
Q2
$145K Hold
6,415
﹤0.01% 2024
2020
Q1
$64.6K Buy
+6,415
New +$62.4K ﹤0.01% 2290

Other funds holding ZYXI

Metropolitan Life Insurance Company (MetLife)'s ZYXI Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Zynex (ZYXI) in Q2 2024, closing a stake of 1,205 shares — an estimated $14.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ZYXI in Q1 2020 and held it in 11 quarters. The position peaked at $145K in Q2 2020. 110 funds tracked by Wall St. Rank hold ZYXI as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Zynex position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,205 Zynex shares in Q2 2024, an estimated $14.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Zynex in Q1 2020 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Zynex position peaked at $145K in Q2 2020.
  • 110 funds tracked by Wall St. Rank held Zynex as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.